Abstract:Objective To study the clinical effect of the application of the interventional embolization of hepatic artery with gelatin sponge particles in the treatment of giant hepatic carcinoma. Methods 91 cases of patients with giant liver cancer were randomly divided into the study group and the control group. The control group only used the iodine oil emulsion in the treatment of hepatic artery interventional chemotherapy embolization. The study group used gelatin sponge particles and iodine oil emulsion combined with the implementation of hepatic arterial chemoembolization. The tumor necrosis rate,the tumor diameter,the level of the fetal protein,liver function,adverse reaction and survival of the follow-up period were compared. Results The tumor necrosis rate in the study group was significantly higher than that in the control group (P < 0. 05). The tumor diameter between two groups had no significant difference (P >0. 05). After 1 month treatment the tumor diameter were significantly reduced (P <0. 05),and the diameter of the tumor in the study group 3 months after treatment was reduced,but had no significant difference compared with 1 month treatment(P > 0. 05). The tumor diameter in the control group was in-creased 3 months after treatment,but there was no significant difference between before operation and 1 months after operation (P >0. 05). There was no significant difference of AFP between the two groups before and after treatment (P > 0. 05),and the two groups were better than before treatment (P <0. 05). The liver function showed no significant difference between the two groups before treatment. After treatment,CHE,ALB,ALT and AST were significantly decreased,and TBIL was not signifi-cantly changed. After treatment,ALB and CHE were significantly decreased, and the other indicators had no significant change. After treatment,the levels of ALT and AST in the study group were significantly higher than those in the control group after treatment,and there were no significant differences between the two groups. There was no significant difference in the in-cidence of adverse reactions between the two groups (P >0. 05). The survival rate of 3 and 6 months after treatment had no significant difference (P >0. 05). The survival rate of 9 months and 12 months after treatment was significantly higher than that of the control group (P < 0. 05). Conclusion Massive type hepatocellular carcinoma (HCC) implementation of he-patic artery interventional embolization with gelatin sponge particles combined with lipiodol emulsion can significantly improve the curative effect in the near future,prolong the survival time of the patients and no significant increase in adverse reactions compared with the simple application of lipiodol emulsion embolization.

Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?

Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness

Transarterial Bleomycin–Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma

Are Autologous Bone Marrow Stem Cell Transplantation and Transcatheter Arterial Embolization the Best Choices for Patients with Hepatocellular Carcinoma and Hepatic Dysfunction? Report of a Case

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma

Percutaneous microwave ablation liver partition and portal vein embolization for planned hepatectomy due to large gastrointestinal stromal tumor metastases: A case report.

Feasibility, Safety, and Efficacy of Ultrasound-Guided Percutaneous Microwave Ablation for Giant Hepatic Hemangioma

Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results

[The New Technology of Enhanced Radiofrequency Ablation is Safe and Effective for Treating Giant Hepatic Hemangioma].

Imaging Characteristics of and Embolization Therapy for Giant Hepatic Hemangioma

Treatment of Giant Hepatic Carcinoma by Transcatheter Arterial Embolization with Gelatin Sponge Particles with Iodine Oil Emulsion

Long-Term Outcomes of Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol-Bleomycin Emulsion

Efficacy, Safety and Feasibility of Ultrasound-Guided Percutaneous Microwave Ablation for Large Hepatic Hemangioma.

Radiofrequency Ablation for Treatment of Giant Hepatic Hemangiomas

Embolotherapy in the Management of Hepatocellular Carcinoma.

Percutaneous microwave ablation versus sclerotherapy for large hepatic hemangioma: a multi-center cohort study

Transarterial Chemoembolization for Huge Hepatocellular Carcinoma with Diameter over Ten Centimeters: a Large Cohort Study

Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas

Endoscopic Ultrasound-Guided Ethanol Injection Associated with Trans-arterial Embolization of a Giant Intra-abdominal Cavernous Hemangioma: Case Report and New Therapeutic Option

Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response